Development of high-viscosity, two-paste bioactive bone cements.

Current bone cements face challenges in thermal control and mechanical performance. Prior research has shown that high exothermic reactions during curing can damage surrounding tissues. It was already known that methacrylate-based systems offer improved adhesion properties. No prior work had resolved the issue of viscosity while maintaining bioactivity. This gap motivated researchers to explore alternative monomer combinations. That uncertainty drove investigations into viscosity modifiers that do not compromise mechanical integrity. Existing methods lacked sufficient extrudability for clinical applications. This paper introduces a novel approach to address these limitations.

The study aimed to develop a two-paste bone cement system with reduced exothermic output. Researchers focused on improving mechanical properties while maintaining bioactivity. They sought to address the limitations of traditional methacrylate-based cements. The goal was to create a formulation that supports better adhesion to bone surfaces. They tested different monomer combinations to find optimal viscosity characteristics. The study also evaluated the impact of mixing methods on cement performance. Researchers wanted to assess the bioactive potential of the new formulation. The ultimate objective was to provide a clinically viable alternative to existing cements.

Researchers formulated two-paste systems containing 60% hydroxyapatite by weight. They used bis-GMA, UDMA, and TEGDMA as methacrylate monomers. A silane coupling agent (A174) was applied to modify hydroxyapatite particles. FT-infrared spectroscopy confirmed successful silane bonding to the ceramic. Two mixing methods were tested: open bowl mixing and auto-mixing via a dispensing gun. The mechanical properties of each cement type were evaluated. Polymerization exotherm was measured using thermal analysis techniques. Bioactivity was assessed by immersing samples in simulated body fluid.

Both cement types exhibited low polymerization exotherms below 60°C. The UDMA-based cement showed improved extrudability compared to bis-GMA. Mechanical testing revealed compressive strengths exceeding 60 MPa. The silane-treated hydroxyapatite showed characteristic carbonyl and Si-O peaks. Apatite layers formed on cement surfaces within 24 hours in simulated body fluid. The UDMA formulation demonstrated better handling properties during mixing. Thermal analysis confirmed no significant differences in curing profiles. The results suggest UDMA is a viable alternative to bis-GMA in cement matrices.

The authors propose that UDMA provides a suitable matrix for bone cement formulations. They suggest that the lower viscosity of UDMA improves extrusion and handling. The study indicates that silane coupling enhances ceramic-polymer interactions. The researchers propose that the new cement maintains bioactive properties. They suggest that the two-paste system reduces exothermic effects during curing. The authors propose that the formulation supports better mechanical performance. The study suggests that the new cement could improve clinical outcomes. The findings indicate that UDMA-based cements warrant further clinical evaluation.